Table 3. One-year relative survival by route, for selected tumours with 95% confidence intervals.

	All routes		Screen-Detected		TWW		GP Referral		Other Outpatient		Inpatient Elective		Emergency Presentation		Unknown
	Survival	95% CI	Survival	95% CI	Survival	95% CI	Survival	95% CI	Survival	95% CI	Survival	95% CI	Survival	95% CI	Survival	95% CI
Bladder	73%	72–73			83%	82–84	79%	78–80	77%	75–79	83%	81–84	36%	35–37	74%	72–77
Central nervous system	39%	39–40			47%	37–57	54%	52–57	62%	59–65	53%	50–57	30%	29–31	50%	46–54
Breast	97%	96–97	100%	100–100	98%	98–98	96%	96–97	92%	91–93	91%	88–93	54%	52–55	95%	95–96
Colorectal	74%	74–74	98%	97–98	82%	82–83	82%	81–83	80%	79–81	84%	83–85	50%	49–51	73%	72–74
Kidney and unspecified urinary organs	69%	68–70			79%	77–80	80%	79–81	82%	81–84	78%	75–80	38%	37–40	63%	60–66
Lung	29%	28–29			40%	39–41	40%	40–41	44%	43–45	34%	33–36	12%	11–12	24%	23–25
Melanoma	97%	97–97			99%	98–99	98%	97–98	94%	92–95	96%	95–98	62%	58–66	99%	98–99
Multiple myeloma	70%	69–71			82%	80–85	81%	79–82	78%	75–80	79%	76–83	51%	49–53	80%	76–83
Non-Hodgkin lymphoma	75%	75–76			85%	84–87	86%	85–87	81%	79–82	84%	81–86	50%	49–51	86%	84–88
Oesophagus	40%	39–40			42%	41–43	47%	45–48	50%	48–53	49%	47–51	18%	17–20	44%	41–48
Ovary	70%	69–70			84%	82–85	81%	79–82	82%	80–84	81%	78–84	45%	44–47	68%	65–71
Pancreas	17%	16–17			19%	18–21	26%	24–27	33%	31–35	29%	26–32	9%	9–10	16%	14–18
Prostate	96%	95–96			98%	97–98	99%	99–99	96%	96–97	99%	99–99	60%	59–62	98%	98–99
Stomach	41%	40–41			43%	42–45	52%	50–54	55%	52–58	53%	51–55	23%	21–24	44%	41–47
Uterus	91%	90–91			94%	94–95	94%	93–94	90%	89–92	93%	91–95	59%	56–61	89%	87–91

Abbreviation: CI=Confidence Interval. Cases diagnosed in persons with an English residential address, 2006–2008.